India says 'examining the implications' of US tariffs
New Delhi, which is in the process of negotiating the first tranche of a bilateral trade agreement with Washington, said it was pushing ahead with talks for a deal.
India's Department of Commerce said it is "carefully examining the implications of the various measures", adding in a statement that it was "also studying the opportunities that may arise due to this new development".
Trump, speaking while unveiling the tariffs at the White House on Wednesday, said that Indian Prime Minister Narendra Modi was a "great friend" but that he had not been "treating us right".
An initial White House chart revealing the tariffs listed India at 26 percent, but a subsequent annex -- cited by New Delhi -- put duties at 27 percent.
"Discussions are ongoing between Indian and US trade teams for the expeditious conclusion of a mutually beneficial, multi-sectoral Bilateral Trade Agreement," the statement said.
The commerce department added that talks "are focused on enabling both nations to grow trade, investments and technology transfers".
"We remain in touch with the Trump Administration on these issues and expect to take them forward in the coming days."
India's pharmaceutical sector, which exported more than $8 billion of products to the United States in the 2024 fiscal year, emerged unscathed -- with drugs exempt from its reciprocal tariff move.